TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million December 6, 1974
TCL Archive An “insurgency” targets randomized trials, demands access to investigational drugs. August 5, 2005